150 related articles for article (PubMed ID: 33422900)
1. Clinicopathologic Characteristics and Prognosis of Invasive Papillary Carcinoma of the Breast.
Huang K; Appiah L; Mishra A; Bagaria SP; Gabriel ME; Misra S
J Surg Res; 2021 May; 261():105-112. PubMed ID: 33422900
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
Chen S; Wang J; Yang L; Ji M; Chen S
J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast: a large case study.
Liu ZY; Liu N; Wang YH; Yang CC; Zhang J; Lv SH; Niu Y
J Cancer Res Clin Oncol; 2013 Jan; 139(1):77-84. PubMed ID: 22932921
[TBL] [Abstract][Full Text] [Related]
4. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
[TBL] [Abstract][Full Text] [Related]
5. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
[TBL] [Abstract][Full Text] [Related]
6. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
7. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
8. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study.
Yu JI; Choi DH; Park W; Huh SJ; Cho EY; Lim YH; Ahn JS; Yang JH; Nam SJ
Breast; 2010 Jun; 19(3):231-7. PubMed ID: 20304650
[TBL] [Abstract][Full Text] [Related]
9. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Br J Cancer; 2014 Jul; 111(3):619-22. PubMed ID: 24921921
[TBL] [Abstract][Full Text] [Related]
10. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
11. Intracystic papillary carcinoma: a review of 917 cases.
Grabowski J; Salzstein SL; Sadler GR; Blair S
Cancer; 2008 Sep; 113(5):916-20. PubMed ID: 18661510
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.
Wu Y; Zhang N; Yang Q
BMC Cancer; 2017 Dec; 17(1):839. PubMed ID: 29228910
[TBL] [Abstract][Full Text] [Related]
13. Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes.
Hassan Z; Boulos F; Abbas J; El Charif MH; Assi H; Sbaity E
Breast Cancer Res Treat; 2020 Jul; 182(2):317-323. PubMed ID: 32462260
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Characteristics and Survival Outcomes in Invasive Papillary Carcinoma of the Breast: A SEER Population-Based Study.
Zheng YZ; Hu X; Shao ZM
Sci Rep; 2016 Apr; 6():24037. PubMed ID: 27053333
[TBL] [Abstract][Full Text] [Related]
15. Invasive Papillary Carcinoma of the Breast: Clinicopathological Features and Hormone Receptor Profile.
Hashmi AA; Munawar S; Rehman N; Ahmed O; Islam S; Asghar IA; Afzal A; Irfan M; Shamail F; Ali SJ
Cureus; 2021 Feb; 13(2):e13480. PubMed ID: 33777568
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic study of invasive micropapillary carcinoma of the breast.
Tang SL; Yang JQ; Du ZG; Tan QW; Zhou YT; Zhang D; Lv Q
Oncotarget; 2017 Jun; 8(26):42455-42465. PubMed ID: 28418916
[TBL] [Abstract][Full Text] [Related]
17. Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.
Hao S; Zhao YY; Peng JJ; Ren F; Yang WT; Yu KD; Shao ZM
Sci Rep; 2019 Jan; 9(1):286. PubMed ID: 30670771
[TBL] [Abstract][Full Text] [Related]
18. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
19. Overall survival is improved when DCIS accompanies invasive breast cancer.
Kole AJ; Park HS; Johnson SB; Kelly JR; Moran MS; Patel AA
Sci Rep; 2019 Jul; 9(1):9934. PubMed ID: 31289308
[TBL] [Abstract][Full Text] [Related]
20. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]